Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9(6):400–414

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arbab IA, Looi CY, Abdul AB, Cheah FK, Wong WF, Sukari MA et al (2012) Dentatin induces apoptosis in prostate cancer cells via Bcl-2, Bcl-xL, Survivin downregulation, caspase-9,-3/7 activation, and NF-κB inhibition. Evid Based Complement Alternat Med 2012:856029

Barani M, Sabir F, Rahdar A, Arshad R, Kyzas GZ (2020) Nanotreatment and nanodiagnosis of prostate cancer: recent updates. Nanomaterials (Basel) 10(9):1696

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68(6):394–424

PubMed  Google Scholar 

Cussenot O, Villette J, Valeri A, Cariou G, Desgrandchamps F, Cortesse A et al (1996) Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma. J Urol 155(4):1340–1343

Article  CAS  PubMed  Google Scholar 

de Oliveira JMPF, Santos C, Fernandes E (2020) Therapeutic potential of hesperidin and its aglycone hesperetin: Cell cycle regulation and apoptosis induction in cancer models. Phytomedicine 73:152887

Article  Google Scholar 

Ebrahimi S, Mirzavi F, Aghaee-Bakhtiari SH (1869) Hashemy SI (2022) SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 5:119221

Google Scholar 

Esteban F, Muñoz M, Gonzalez-Moles M, Rosso M (2006) A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev 25(1):137–145

Article  CAS  PubMed  Google Scholar 

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al (2018) Global cancer observatory: cancer today. Lyon, France. Int Agency Res Cancer 3(20):2019

Google Scholar 

Ghahremanloo A, Javid H, Afshari AR, Hashemy SI (2021) Investigation of the role of neurokinin-1 receptor inhibition using aprepitant in the apoptotic cell death through PI3K/Akt/NF-κB signal transduction pathways in colon cancer cells. BioMed Res Int 2021:Article ID 1383878

Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21(1):11–19

Article  CAS  PubMed  Google Scholar 

Javid H, Asadi J, Zahedi Avval F, Afshari AR, Hashemy SI (2020) The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways. Mol Biol Rep 47(3):2253–2263

Article  CAS  PubMed  Google Scholar 

Javid H, Ghahremanloo A, Afshari AR, Salek R, Hashemy SI (2022a) The Emerging Role of Neurokinin-1 Receptor Blockade Using Aprepitant in the Redox System of Esophageal Squamous Cell Carcinoma. Int J Pept Res Ther 28(3):1–13

Article  Google Scholar 

Javid H, Hashemy SI, Heidari MF, Esparham A, Gorgani-Firuzjaee S (2022b) The anticancer role of cerium oxide nanoparticles by inducing antioxidant activity in esophageal cancer and cancer stem-like ESCC spheres. BioMed Res Int 2022:3268197

Kabala-Dzik A, Rzepecka-Stojko A, Kubina R, Iriti M, Wojtyczka RD, Buszman E et al (2018) Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7: A comparative study. Cell Mol Biol (Noisy-le-grand) 25;64(8):1–10

Katzenwadel A, Wolf P (2015) Androgen deprivation of prostate cancer: Leading to a therapeutic dead end. Cancer Lett 367(1):12–17

Article  CAS  PubMed  Google Scholar 

Kim J, Kim J, Bae J-S (2016) ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med 48(11):e269-e

Article  Google Scholar 

Kirkin V, Joos S, Zörnig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1644(2–3):229–49

Article  CAS  Google Scholar 

Lee CJ, Wilson L, Jordan MA, Nguyen V, Tang J, Smiyun G (2010) Hesperidin suppressed proliferations of both Human breast cancer and androgen-dependent prostate cancer cells. Phytother Res 24(S1):S15–S19

Article  PubMed  Google Scholar 

Lee D-H, Park K-I, Park H-S, Kang S-R, Nagappan A, Kim J-A, et al. (2012) Flavonoids isolated from Korea Citrus aurantium L. induce G2/M phase arrest and apoptosis in human gastric cancer AGS cells. Evid Based Complement Alternat Med. 2012

Li C, Schluesener H (2017) Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr 57(3):613–631

Article  CAS  PubMed  Google Scholar 

Moloney JN, Cotter TG (eds) (2018) ROS signalling in the biology of cancer. Semin Cell Dev Biol 80:50–64

Muller PA, Vousden KH, Norman JC (2011) p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192(2):209–218

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muñoz M, Coveñas R (2020) The neurokinin-1 receptor antagonist aprepitant: an intelligent bullet against cancer? Cancers 12(9):2682

Article  PubMed  PubMed Central  Google Scholar 

Muñoz M, Rosso M (2010) The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Invest New Drugs 28(2):187–193

Article  PubMed  Google Scholar 

Nakazawa M, Paller C, Kyprianou N (2017) Mechanisms of therapeutic resistance in prostate cancer. Curr Oncol Rep 19(2):1–12

Article  Google Scholar 

Ning L, Zhao W, Gao H, Wu Y (2020) Hesperidin induces anticancer effects on human prostate cancer cells via ROS-mediated necrosis like cell death. J BUON 25(6):2629–2634

PubMed  Google Scholar 

O’brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267(17):5421–6

Article  PubMed  Google Scholar 

Obata K, Shimo T, Okui T, Matsumoto K, Takada H, Takabatake K et al (2016) Tachykinin receptor 3 distribution in human oral squamous cell carcinoma. Anticancer Res 36(12):6335–6341

Article  CAS  PubMed  Google Scholar 

O’Neill D, Jones D, Wade M, Grey J, Nakjang S, Guo W et al (2015) Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget 6(28):26029

Article  PubMed  PubMed Central  Google Scholar 

Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 47(19):6645–6653

Article  CAS  PubMed  Google Scholar 

Pandey P, Khan F (2021) A mechanistic review of the anticancer potential of hesperidin, a natural flavonoid from citrus fruits. Nutr Res 92:21–31

Article  CAS  PubMed  Google Scholar 

Rydzewska LH, Burdett S, Vale CL, Clarke NW, Fizazi K, Kheoh T et al (2017) Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. Eur J Cancer 84:88–101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanwar B, Modgil R (2012) Flavonoids: Dietary occurrence and health benefits. Spatula Dd 2(1):59–68

Article  Google Scholar 

Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281(5383):1680–1683

Article  CAS  PubMed  Google Scholar 

Zhang Y, Liu X, Ruan J, Zhuang X, Zhang X, Li Z (2020) Phytochemicals of garlic: Promising candidates for cancer therapy. Biomed Pharmacother 123:109730

Article  PubMed  Google Scholar